SCYX - Scynexis hit by FDA clinical hold on antifungal trials
2023-10-02 11:41:56 ET
More on SCYNEXIS
- Scynexis: From Fungal To Bungle, The Brexafemme Recall And A Slippery Slope (Rating Downgrade)
- Scynexis recalling antifungal therapy on potential contamination
- Seeking Alpha’s Quant Rating on SCYNEXIS
- Historical earnings data for SCYNEXIS
- Financial information for SCYNEXIS
For further details see:
Scynexis hit by FDA clinical hold on antifungal trials